Home

VICKI L SATO

CIK 1197020 · last filed 2026-06-23

VICKI L SATO is a corporate insider who has filed 162 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing, for ALLO, was dated Jun 23, 2026. Across all open-market trades the lifetime net is −$19.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $16.3M across reported positions. 9 SEC filings were submitted jointly with BORGWARNER INC.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$16.34M

Companies

10

Total Filings

162

Lifetime Open-Market Net

-$19.53M

Filer Profile

Reported Address
940 WINTER STREET
PERKINELMER, INC. LEGAL DEPARTMENT
WALTHAM, MA 02451
Related Filers
BORGWARNER INC — 9 joint filings, latest 2020-05-01
ALNYLAM PHARMACEUTICALS, INC. — 6 joint filings, latest 2010-06-04
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
ALLO Director 162,575 $1.97 $320.3K $0 6 2026-06-23
VIR Director 1,078,391 $11.38 $12.28M -$13.98M 43 2026-05-04
DNLI Director 107,976 $22.28 $2.41M -$1.78M 37 2025-01-03
Akouos, Inc. (AKUS) Delisted Director — $13.29 — $0 3 2022-12-02
BMY Director — $66.82 — $0 22 2021-02-03
BWA Director 19,823 $67.54 $1.34M $0 7 2020-05-01
Syros Pharmaceuticals, Inc. (SYRS) Delisted Director — $0.00 — $0 5 2019-06-12
REVVITY, INC. (PKI) Delisted Director 29,970 $115.24 $3.45M -$3.78M 16 2017-02-10
ALNY Director — $266.11 — $0 4 2010-06-04
INFINITY PHARMACEUTICALS, INC. (INFI) Delisted Director — $0.04 — $0 2 2008-05-23

Recent Filings

162 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-23 ALLO Grant (A) — $0 EDGAR
2026-05-04 VIR Sell (S) −22,000 -$221.0K EDGAR
2026-04-02 VIR Sell (S) −22,000 -$199.6K EDGAR
2026-03-03 VIR Sell (S) −22,000 -$209.2K EDGAR
2026-03-02 VIR Notice (144) −88,000 -$799.9K EDGAR
2026-02-26 VIR Mixed — -$350.4K EDGAR
2026-02-24 VIR Notice (144) −20,377 -$151.4K EDGAR
2026-02-03 VIR Sell (S) −22,000 -$169.7K EDGAR
2026-01-05 VIR Sell (S) −22,000 -$130.4K EDGAR
2026-01-02 VIR Notice (144) −66,000 -$398.0K EDGAR
Showing 1–10 of 162
Page 1 of 17
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.